Literature DB >> 21079410

Initial visual acuity is an important prognostic factor in patients with branch retinal vein occlusion.

Jiri Rehak1, Ladislav Dusek, Oldrich Chrapek, Evzen Fric, Matus Rehak.   

Abstract

PURPOSE: To evaluate the role of initial visual acuity (VA) as a potential prognostic factor for final VA in patients with branch retinal vein occlusion (BRVO).
METHODS: A retrospective data analysis involving 163 patients with macular edema secondary to BRVO treated according to the recommendations of the Branch Vein Occlusion Study Group was performed using univariate and multivariate logistic regression models, and receiver-operating characteristics analysis. The analyses take factors into account that can potentially influence final visual result: sex, age, type of occlusion (major temporal or macular), grid photocoagulation and ischemia.
RESULTS: The final VA ≤ 0.1 was statistically significantly related to initial VA ≤ 0.16 and age > 70 years. Sex, type of occlusion, grid photocoagulation and ischemia did not significantly influence the prediction of final VA based on age and initial VA.
CONCLUSIONS: The analysis shows that initial VA and age > 70 years significantly influence the prognosis for final visual results in patients with BRVO.
Copyright © 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2010        PMID: 21079410     DOI: 10.1159/000321701

Source DB:  PubMed          Journal:  Ophthalmic Res        ISSN: 0030-3747            Impact factor:   2.892


  8 in total

1.  Efficacy of intravitreal bevacizumab for macular edema following branch retinal vein occlusion stratified by baseline visual acuity.

Authors:  Mirae Kim; Seongyong Jeong; Min Sagong
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-10-29       Impact factor: 3.117

2.  Visual function after pars plana vitrectomy in macular edema with branch retinal vein occlusion.

Authors:  Hidetaka Noma; Katsunori Shimada; Tatsuya Mimura
Journal:  Int Ophthalmol       Date:  2012-11-19       Impact factor: 2.031

3.  [Intravitreal treatment of patients with branch retinal vein occlusion depending on the duration of macular edema].

Authors:  M Rehak; E Spies; M Scholz; P Wiedemann
Journal:  Ophthalmologe       Date:  2013-10       Impact factor: 1.059

Review 4.  New Developments in the Classification, Pathogenesis, Risk Factors, Natural History, and Treatment of Branch Retinal Vein Occlusion.

Authors:  Jia Li; Yannis M Paulus; Yuanlu Shuai; Wangyi Fang; Qinghuai Liu; Songtao Yuan
Journal:  J Ophthalmol       Date:  2017-03-12       Impact factor: 1.909

5.  Six-month results of intravitreal ranibizumab for macular edema after branch retinal vein occlusion in a single-center prospective study: visual outcomes and microaneurysm formation.

Authors:  Mihoko Kawamura; Yoshio Hirano; Munenori Yoshida; Takeshi Mizutani; Kazuhiko Sugitani; Tsutomu Yasukawa; Yuichiro Ogura
Journal:  Clin Ophthalmol       Date:  2018-08-20

6.  Characteristics of major and macular branch retinal vein occlusion.

Authors:  Yu-Jin Choi; Donghyun Jee; Jin-Woo Kwon
Journal:  Sci Rep       Date:  2022-08-18       Impact factor: 4.996

7.  Microaneurysms cause refractory macular edema in branch retinal vein occlusion.

Authors:  Taneto Tomiyasu; Yoshio Hirano; Munenori Yoshida; Norihiro Suzuki; Takeshi Nishiyama; Akiyoshi Uemura; Tsutomu Yasukawa; Yuichiro Ogura
Journal:  Sci Rep       Date:  2016-07-08       Impact factor: 4.379

8.  Retinal vascular occlusion: a window to diagnosis of familial and acquired thrombophilia and hypofibrinolysis, with important ramifications for pregnancy outcomes.

Authors:  Stephan G Dixon; Carl T Bruce; Charles J Glueck; Robert A Sisk; Robert K Hutchins; Vybhav Jetty; Ping Wang
Journal:  Clin Ophthalmol       Date:  2016-08-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.